KDM6A

Lysine Demethylase 6A: A Key Epigenetic Regulator in Development and Disease

Gene Information Card

Symbol KDM6A
Full Name Lysine Demethylase 6A
Gene Type Protein coding
Chromosomal Location Xp11.3
NCBI Gene ID 7403 ncbi.nlm.nih.gov/gene/7403
Ensembl ID ENSG00000147050
UniProt ID O15550
OMIM ID 300128
HGNC ID 12637
Aliases UTX, bA386N14.2, KABUK1

Description

KDM6A (lysine demethylase 6A) encodes a histone demethylase that specifically demethylates di- and tri-methylated lysine 27 of histone H3 (H3K27me2/me3), a repressive chromatin mark. It is a component of the MLL2/COMPASS-like complex and plays a critical role in transcriptional activation, embryonic development, and cell differentiation. Loss-of-function mutations in KDM6A are associated with Kabuki syndrome and various cancers, including multiple myeloma and bladder cancer.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Kabuki syndrome Loss-of-function mutations lead to haploinsufficiency, disrupting H3K27me3 demethylation and gene expression during development OMIM #300867; ClinVar
Multiple myeloma Somatic mutations and deletions contribute to tumorigenesis by altering epigenetic regulation COSMIC; NCBI
Bladder cancer Frequent inactivating mutations promote cancer progression through aberrant histone methylation COSMIC; NCBI
Acute myeloid leukemia Recurrent mutations impair hematopoietic differentiation COSMIC; NCBI

Expression Profile

Tissue Expression
Tissue nTPM level
Bone marrow 12.5 Medium
Brain 8.3 Low
Kidney 15.2 Medium
Liver 10.1 Medium
Lung 9.7 Low
Testis 18.4 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 14.5 Embryonic kidney cells
K562 11.2 Leukemia cell line
MCF7 9.8 Breast cancer cell line
HepG2 13.1 Liver cancer cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.2971C>T (p.Gln991*) Nonsense <1% Loss of function; truncation
c.3682_3683del (p.Glu1228fs) Frameshift <1% Loss of function; protein truncation
c.1120G>A (p.Gly374Arg) Missense <0.5% Likely loss of function; impaired demethylase activity
c.2071C>T (p.Arg691*) Nonsense <1% Loss of function; nonsense-mediated decay
Mutation functional classification

Loss of Function (LOF)

Most KDM6A mutations in Kabuki syndrome and cancer are loss-of-function, leading to reduced H3K27me3 demethylation and altered gene expression.

Gain of Function (GOF)

Gain-of-function mutations are not well-documented for KDM6A; the gene primarily acts as a tumor suppressor.

Dominant Negative (DN)

Dominant-negative effects are not established; haploinsufficiency is the primary mechanism in Kabuki syndrome.

Gene Ontology (GO)

• Histone H3K27 demethylase activity (GO:0071558) Chromatin binding (GO:0003682)
Transcription coactivator activity (GO:0003713) Nucleus (GO:0005634)
DNA-templated (GO:0006355)

Pathways

Chromatin modifying enzymes (Reactome: R-HSA-3247509)
Transcriptional regulation by MLL2/COMPASS complex (Reactome: R-HSA-8878171)
Epigenetic regulation of gene expression (KEGG: hsa05202)

Protein Summary

KDM6A (UTX) is a 1401-amino acid protein containing a JmjC domain responsible for demethylase activity. It removes methyl groups from H3K27me2/me3, promoting an open chromatin state and gene activation. The protein interacts with multiple transcription factors and chromatin remodelers, including MLL2, and is essential for normal development. Mutations that disrupt its catalytic activity or protein stability lead to disease.

Related Products

Product name Cat.No. Species Gene ID
KDM6A Knockout HEK293 Cell Line EDJ-KQ1956 Human 7403 Details Get a Quote
KDM6A Knockout A-549 Cell Line EDJ-KQ21908 Human 7403 Details Get a Quote
KDM6A Knockout HCT 116 Cell Line EDJ-KQ21909 Human 7403 Details Get a Quote
KDM6A Knockout HeLa Cell Line EDJ-KQ21910 Human 7403 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: